학술논문

Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation
Document Type
article
Source
Stem Cell Reports. 14(3)
Subject
Biological Sciences
Genetics
Huntington's Disease
Brain Disorders
Stem Cell Research - Nonembryonic - Non-Human
Stem Cell Research - Induced Pluripotent Stem Cell - Human
Rare Diseases
Stem Cell Research - Nonembryonic - Human
Neurodegenerative
Stem Cell Research
Regenerative Medicine
Stem Cell Research - Induced Pluripotent Stem Cell
Neurosciences
Development of treatments and therapeutic interventions
Aetiology
5.1 Pharmaceuticals
2.1 Biological and endogenous factors
Neurological
Adult
Age of Onset
Cell Cycle
Cell Differentiation
Cells
Cultured
Epigenesis
Genetic
Humans
Huntington Disease
Induced Pluripotent Stem Cells
Mitosis
Neostriatum
Neural Stem Cells
Neurons
Transcription Factors
Transcriptome
Up-Regulation
Wnt Signaling Pathway
Huntington's disease
WNT signaling
adult-onset HD
cell cycle
development
induced pluripotent stem cells
medium spiny neurons
neural stem cells
single-cell RNA-seq
Biochemistry and Cell Biology
Clinical Sciences
Biochemistry and cell biology
Language
Abstract
Aberrant neuronal development and the persistence of mitotic cellular populations have been implicated in a multitude of neurological disorders, including Huntington's disease (HD). However, the mechanism underlying this potential pathology remains unclear. We used a modified protocol to differentiate induced pluripotent stem cells (iPSCs) from HD patients and unaffected controls into neuronal cultures enriched for medium spiny neurons, the cell type most affected in HD. We performed single-cell and bulk transcriptomic and epigenomic analyses and demonstrated that a persistent cyclin D1+ neural stem cell (NSC) population is observed selectively in adult-onset HD iPSCs during differentiation. Treatment with a WNT inhibitor abrogates this NSC population while preserving neurons. Taken together, our findings identify a mechanism that may promote aberrant neurodevelopment and adult neurogenesis in adult-onset HD striatal neurons with the potential for therapeutic compensation.